COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
Abstract A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become
a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …
a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …
COVID-19 and chronic kidney disease: a comprehensive review
IMD Pecly, RB Azevedo, ES Muxfeldt… - Brazilian Journal of …, 2021 - SciELO Brasil
Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with
increased in-hospital mortality and worse clinical evolution, raising concerns towards …
increased in-hospital mortality and worse clinical evolution, raising concerns towards …
Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention
JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …
with potentially informative findings from prior research literature and to promote …
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
R Subir - Diabetes & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aims Morbidity and mortality from coronavirus disease 2019 (COVID-19) is
higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease …
higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease …
[HTML][HTML] SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease
COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …
[HTML][HTML] Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients–A narrative review and hypotheses
AS Gouda, FG Adbelruhman, HS Alenezi… - Saudi Journal of …, 2021 - Elsevier
The world is currently facing a frightening coronavirus disease-2019 (COVID-19) epidemic.
Severity of COVID-19 presentation is highly variable among infected individuals with …
Severity of COVID-19 presentation is highly variable among infected individuals with …
Immune landscape and redox imbalance during neurological disorders in COVID-19
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has prompted the scientific
community to explore potential treatments or vaccines against severe acute respiratory …
community to explore potential treatments or vaccines against severe acute respiratory …
Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors …
R Sarangarajan, R Winn, MA Kiebish… - Journal of Racial and …, 2021 - Springer
Rationale Hypertension, obesity and diabetes are major risk factors associated with
morbidities underlying COVID-19 infections. Regression analysis correlated presence of …
morbidities underlying COVID-19 infections. Regression analysis correlated presence of …
The Yin and Yang of ACE/ACE2 pathways: the rationale for the use of renin-angiotensin system inhibitors in COVID-19 patients
L Zamai - Cells, 2020 - mdpi.com
The article describes the rationale for inhibition of the renin-angiotensin system (RAS)
pathways as specific targets in patients infected by SARS-CoV-2 in order to prevent positive …
pathways as specific targets in patients infected by SARS-CoV-2 in order to prevent positive …
Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID‐19?
AS Gouda, B Mégarbane - Drug Development Research, 2021 - Wiley Online Library
The severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2), a novel coronavirus
responsible for the recent infectious pandemic, is known to downregulate angiotensin …
responsible for the recent infectious pandemic, is known to downregulate angiotensin …